The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies.
Publication: Environmental Health Perspectives
Volume 111, Issue 12
Pages 1530 - 1549
Abstract
The Organisation for Economic Co-operation and Development has completed phase 2 of an international validation program for the rodent uterotrophic bioassay. The purpose of the validation program was to demonstrate the performance of two versions of the uterotrophic bioassay, the immature female rat and the adult ovariectomized rat, in four standardized protocols. This article reports the dose-response studies of the validation program; the coded single-dose studies are reported in an accompanying paper. The dose-response study design used five selected weak estrogen agonists, bisphenol A, genistein, methoxychlor, nonylphenol, and o,p -DDT. These weak agonists were administered in a prescribed series of doses to measure the performance and reproducibility of the protocols among the participating laboratories. All protocols successfully detected increases in uterine weights when the weak agonists were administered. Within each protocol, there was good agreement and reproducibility of the dose response among laboratories with each substance. Substance-specific variations were observed in the influence of the route of administration on the uterine response, the potency as related to the dose producing the first statistically significant increase in uterine weights, and the maximum increase in uterine weight. Substantive performance differences were not observed between the uterotrophic bioassay versions or among the standardized protocols, and these were judged to be qualitatively equivalent. It is noteworthy that these results were reproducible under a variety of different experimental conditions (e.g., animal strain, diet, housing, bedding, vehicle, animal age), indicating that the bioassay's performance as a screen is robust. In conclusion, both the intact, immature, and adult OVX versions, and all protocols appear to be reproducible and transferable across laboratories and are able to detect weak estrogen agonists.
Formats available
You can view the full content in the following formats:
Information & Authors
Information
Published In
Environmental Health Perspectives
Volume 111 • Issue 12 • September 2003
Pages: 1530 - 1549
PubMed: 12948896
License Information
EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
History
Published online: 1 September 2003
Authors
Metrics & Citations
Metrics
Citations
Download citation
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click DOWNLOAD.
Cited by
- Singh A, Singh S, Davidov O, Optimal designs for testing pairwise differences: A graph‐based game theoretic approach, Scandinavian Journal of Statistics, 10.1111/sjos.12757, (2024).
- Abe N, Sakiyama A, Suzuki M, Win-Shwe T, Suzuki T, Kawashima T, Tsukahara S, Ethynylestradiol feminizes gene expression partly in testis developing as ovotestis and disrupts asymmetric Müllerian duct development by eliminating asymmetric gene expression in Japanese quail embryos, Toxicological Sciences, 10.1093/toxsci/kfae033, 199, 2, (210-226), (2024).
- Ishida K, Furukawa M, Kunitani M, Yamagiwa R, Hiromori Y, Matsumaru D, Hu J, Nagase H, Nakanishi T, Novel, highly sensitive, in vivo screening method detects estrogenic activity at low doses of bisphenol A, Journal of Hazardous Materials, 10.1016/j.jhazmat.2022.130461, 445, (130461), (2023).
- Win‐Shwe T, Abe N, Sakiyama A, Suzuki M, Sano K, Kawashima T, Tsukahara S, In ovo o , p ′‐DDT exposure induces malformation of reproductive organs and alters the expression of genes controlling sexual differentiation in Japanese quail embryo , Journal of Applied Toxicology, 10.1002/jat.4571, 44, 5, (699-711), (2023).
- Vandenberg L, Pelch K, Systematic Review Methodologies and Endocrine Disrupting Chemicals: Improving Evaluations of the Plastic Monomer Bisphenol A, Endocrine, Metabolic & Immune Disorders - Drug Targets, 10.2174/1871530321666211005163614, 22, 7, (748-764), (2022).
- Ishida K, Matsumaru D, Shimizu S, Hiromori Y, Nagase H, Nakanishi T, Evaluation of the Estrogenic Action Potential of Royal Jelly by Genomic Signaling Pathway in Vitro and in Vivo, Biological and Pharmaceutical Bulletin, 10.1248/bpb.b22-00383, 45, 10, (1510-1517), (2022).
- Thambirajah A, Wade M, Verreault J, Buisine N, Alves V, Langlois V, Helbing C, Disruption by stealth - Interference of endocrine disrupting chemicals on hormonal crosstalk with thyroid axis function in humans and other animals, Environmental Research, 10.1016/j.envres.2021.111906, 203, (111906), (2022).
- Lee H, Hwangbo H, Ji S, Oh S, Byun K, Park J, Lee B, Kim G, Choi Y, Safety effect of fermented oyster extract on the endocrine disruptor assay in vitro and in vivo, Fisheries and Aquatic Sciences, 10.47853/FAS.2021.e32, 24, 10, (330-339), (2021).
- Søgaard R, Holbech H, Nørum U, Bjerregaard P, Investigation of the in vivo estrogenicity of the UV-filters 4-methylbenzylidene camphor and octyl methoxy cinnamate in rainbow trout (Oncorhynchus mykiss), Ecotoxicology and Environmental Safety, 10.1016/j.ecoenv.2021.112657, 224, (112657), (2021).
- Vandenberg L, Toxicity testing and endocrine disrupting chemicals, Endocrine-Disrupting Chemicals, 10.1016/bs.apha.2021.05.001, (35-71), (2021).